Loading...

London Edythe

Title(s)Professor In-Residence, Psychiatry and Biobehavioral Sciences
Phone(310) 825-0606
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Exercise in Methamphetamine Use Disorder: Dopamine Receptor Upregulation and Neural Function
    NIH/NIDA R01DA045162Jul 1, 2018 - Apr 30, 2023
    Role: Principal Investigator
    Neural substrates of cigarette craving, withdrawal, and relief: male-female differences
    NIH/NIDA R01DA044467Sep 1, 2017 - Aug 31, 2020
    Role: Principal Investigator
    Neural substrates of cigarette craving, withdrawal, and relief: male-female differences
    NIH/NIDA R37DA044467Sep 1, 2017 - Aug 31, 2020
    Role: Principal Investigator
    Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
    NIH/NIDA R21DA042347Jun 1, 2017 - May 31, 2019
    Role: Principal Investigator
    Effects of Oral Contraceptives on Emotion Regulation
    NIH/NIDA R21DA040168Aug 15, 2016 - Jul 31, 2018
    Role: Principal Investigator
    Attentional Bias Modification in Methamphetamine Use Disorder
    NIH/NIDA R21DA040156Jul 1, 2015 - Jun 30, 2017
    Role: Principal Investigator
    Behavioral and Neural Response to Reduced Nicotine Cigarettes in Young Smokers
    NIH/NIDA R01DA036487Sep 30, 2013 - Aug 31, 2016
    Role: Principal Investigator
    Neural Substrates of Emotion Regulation in Premenstrual Dysphoric Disorder
    NIH/NIMH R21MH098668May 1, 2013 - Apr 30, 2015
    Role: Principal Investigator
    UCLA Training Program in the Translational Neuroscience of Drug Abuse (TNDA)
    NIH/NIDA T32DA024635Jul 1, 2008 - Jun 30, 2023
    Role: Principal Investigator
    Response Inhibition and Dopamine Neurotransmission (RI) (4 of 8)
    NIH/NIDA RL1DA024853Sep 30, 2007 - Oct 31, 2013
    Role: Principal Investigator
    Methamphetamine Abuse, Inhibitory Control: Implications for Treatment
    NIH/NIDA P20DA022539Sep 30, 2006 - Apr 30, 2011
    Role: Principal Investigator
    Neural Systems, Inhibitory Control, and Methamphetamine Dependence
    NIH/NIDA R01DA020726Sep 30, 2005 - Aug 31, 2010
    Role: Principal Investigator
    Early Methamphetamine Abstinence: fMRI and Cognition
    NIH/NIDA R01DA015179Sep 1, 2003 - Jun 30, 2007
    Role: Principal Investigator
    Nicotine Withdrawal, Smoking &Cognition: an fMRI Study
    NIH/NIDA R01DA014093Sep 30, 2001 - Apr 30, 2006
    Role: Principal Investigator
    Human Brain Function And Drug Abuse
    NIH/NIDA Z01DA000385
    Role: Co-Principal Investigator
    NEUROCHEMICAL INTERACTIONS AND BEHAVIOR SEQUELLA IN MODELS OF DRUG ABUSE
    NIH/NIDA Z01DA000386
    Role: Principal Investigator
    FUNCTIONAL CHARACTERIZATION OF ANATOMICAL SITES ASSOCIATED WITH WITHDRAWAL
    NIH/NIDA Z01DA000395
    Role: Co-Principal Investigator
    Biochemistry Of Ligand Gated Ion Channels Important To D
    NIH/NIDA Z01DA000403
    Role: Co-Principal Investigator
    Development Of New Approaches To Neuroimaging with PET and SPECT
    NIH/NIDA Z01DA000405
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Thorberg FA, Young RM, Hasking P, Lyvers M, Connor JP, London ED, Huang YL, Feeney GFX. Alexithymia and Alcohol Dependence: The Roles of Negative Mood and Alcohol Craving. Subst Use Misuse. 2019 Aug 20; 1-7. PMID: 31429362.
      View in: PubMed
    2. Lam M, Hill WD, Trampush JW, Yu J, Knowles E, Davies G, Stahl E, Huckins L, Liewald DC, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Hartmann AM, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways. Am J Hum Genet. 2019 Aug 01; 105(2):334-350. PMID: 31374203.
      View in: PubMed
    3. Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse. 2019 Jul 31; 1-17. PMID: 31365275.
      View in: PubMed
    4. Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Ragnhild B, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, Hester R, Jester JM, Karoly HC, Kräplin A, Kreusch F, Landrø NI, Littel M, Steins-Loeber S, London ED, López-Caneda E, Lubman DI, Luijten M, Marczinski CA, Metrik J, Montgomery C, Papachristou H, Mi Park S, Paz AL, Petit G, Prisciandaro JJ, Quednow BB, Ray LA, Roberts CA, Roberts GMP, de Ruiter MB, Rupp CI, Steele VR, Sun D, Takagi M, Tapert SF, Holst RJV, Verdejo-Garcia A, Vonmoos M, Wojnar M, Yao Y, Yücel M, Zack M, Zucker RA, Huizenga HM, Wiers RW. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders. Neurosci Biobehav Rev. 2019 Jul 15. PMID: 31319124.
      View in: PubMed
    5. Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, Hagenaars SP, Ritchie SJ, Marioni RE, Fawns-Ritchie C, Liewald DCM, Okely JA, Ahola-Olli AV, Barnes CLK, Bertram L, Bis JC, Burdick KE, Christoforou A, DeRosse P, Djurovic S, Espeseth T, Giakoumaki S, Giddaluru S, Gustavson DE, Hayward C, Hofer E, Ikram MA, Karlsson R, Knowles E, Lahti J, Leber M, Li S, Mather KA, Melle I, Morris D, Oldmeadow C, Palviainen T, Payton A, Pazoki R, Petrovic K, Reynolds CA, Sargurupremraj M, Scholz M, Smith JA, Smith AV, Terzikhan N, Thalamuthu A, Trompet S, van der Lee SJ, Ware EB, Windham BG, Wright MJ, Yang J, Yu J, Ames D, Amin N, Amouyel P, Andreassen OA, Armstrong NJ, Assareh AA, Attia JR, Attix D, Avramopoulos D, Bennett DA, Böhmer AC, Boyle PA, Brodaty H, Campbell H, Cannon TD, Cirulli ET, Congdon E, Conley ED, Corley J, Cox SR, Dale AM, Dehghan A, Dick D, Dickinson D, Eriksson JG, Evangelou E, Faul JD, Ford I, Freimer NA, Gao H, Giegling I, Gillespie NA, Gordon SD, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Hartmann AM, Hatzimanolis A, Heiss G, Holliday EG, Joshi PK, Kähönen M, Kardia SLR, Karlsson I, Kleineidam L, Knopman DS, Kochan NA, Konte B, Kwok JB, Le Hellard S, Lee T, Lehtimäki T, Li SC, Lill CM, Liu T, Koini M, London E, Longstreth WT, Lopez OL, Loukola A, Luck T, Lundervold AJ, Lundquist A, Lyytikäinen LP, Martin NG, Montgomery GW, Murray AD, Need AC, Noordam R, Nyberg L, Ollier W, Papenberg G, Pattie A, Polasek O, Poldrack RA, Psaty BM, Reppermund S, Riedel-Heller SG, Rose RJ, Rotter JI, Roussos P, Rovio SP, Saba Y, Sabb FW, Sachdev PS, Satizabal CL, Schmid M, Scott RJ, Scult MA, Simino J, Slagboom PE, Smyrnis N, Soumaré A, Stefanis NC, Stott DJ, Straub RE, Sundet K, Taylor AM, Taylor KD, Tzoulaki I, Tzourio C, Uitterlinden A, Vitart V, Voineskos AN, Kaprio J, Wagner M, Wagner H, Weinhold L, Wen KH, Widen E, Yang Q, Zhao W, Adams HHH, Arking DE, Bilder RM, Bitsios P, Boerwinkle E, Chiba-Falek O, Corvin A, De Jager PL, Debette S, Donohoe G, Elliott P, Fitzpatrick AL, Gill M, Glahn DC, Hägg S, Hansell NK, Hariri AR, Ikram MK, Jukema JW, Vuoksimaa E, Keller MC, Kremen WS, Launer L, Lindenberger U, Palotie A, Pedersen NL, Pendleton N, Porteous DJ, Räikkönen K, Raitakari OT, Ramirez A, Reinvang I, Rudan I, Schmidt R, Schmidt H, Schofield PW, Schofield PR, Starr JM, Steen VM, Trollor JN, Turner ST, Van Duijn CM, Villringer A, Weinberger DR, Weir DR, Wilson JF, Malhotra A, McIntosh AM, Gale CR, Seshadri S, Mosley TH, Bressler J, Lencz T, Deary IJ. Author Correction: Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2019 May 01; 10(1):2068. PMID: 31043617.
      View in: PubMed
    6. Petzold J, Kienast A, Lee Y, Pooseh S, London ED, Goschke T, Smolka MN. Baseline impulsivity may moderate L-DOPA effects on value-based decision-making. Sci Rep. 2019 Apr 04; 9(1):5652. PMID: 30948756.
      View in: PubMed
    7. Zorick T, Okita K, Mandelkern MA, London ED, Brody AL. Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. Int J Neuropsychopharmacol. 2019 Apr 01; 22(4):286-291. PMID: 30753467.
      View in: PubMed
    8. Tang J, O'Neill J, Alger JR, Shen Z, Johnson MC, London ED. N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users. Int J Neuropsychopharmacol. 2019 Jan 01; 22(1):1-9. PMID: 29788422.
      View in: PubMed
    9. Ahmadi J, Jahromi MS, Ghahremani D, London ED. Single high-dose buprenorphine for opioid craving during withdrawal. Trials. 2018 Dec 10; 19(1):675. PMID: 30526648.
      View in: PubMed
    10. Burggren AC, Siddarth P, Mahmood Z, London ED, Harrison TM, Merrill DA, Small GW, Bookheimer SY. Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use. Cannabis Cannabinoid Res. 2018; 3(1):242-251. PMID: 30547094.
      View in: PubMed
    11. Dean AC, Nurmi EL, Moeller SJ, Amir N, Rozenman M, Ghahremani DG, Johnson M, Berberyan R, Hellemann G, Zhang Z, London ED. No effect of attentional bias modification training in methamphetamine users receiving residential treatment. Psychopharmacology (Berl). 2019 Feb; 236(2):709-721. PMID: 30415277.
      View in: PubMed
    12. Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL, Seaman LC, Mandelkern MA. Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study. Psychopharmacology (Berl). 2018 Dec; 235(12):3525-3534. PMID: 30343364.
      View in: PubMed
    13. Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, Allen NB, Alia-Klein N, Batalla A, Blaine S, Brooks S, Caparelli E, Chye YY, Cousijn J, Dagher A, Desrivieres S, Feldstein-Ewing S, Foxe JJ, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hester R, Hutchison K, Korucuoglu O, Li CR, London E, Lorenzetti V, Luijten M, Martin-Santos R, May A, Momenan R, Morales A, Paulus MP, Pearlson G, Rousseau ME, Salmeron BJ, Schluter R, Schmaal L, Schumann G, Sjoerds Z, Stein DJ, Stein EA, Sinha R, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Whittle S, Wright MJ, Yücel M, Zhang S, Yurgelun-Todd D, Hibar DP, Jahanshad N, Evans A, Thompson PM, Glahn DC, Conrod P, Garavan H. Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. Am J Psychiatry. 2019 Feb 01; 176(2):119-128. PMID: 30336705.
      View in: PubMed
    14. Faulkner P, Ghahremani DG, Tyndale RF, Paterson NE, Cox C, Ginder N, Hellemann G, London ED. Neural basis of smoking-induced relief of craving and negative affect: Contribution of nicotine. Addict Biol. 2018 Oct 11. PMID: 30307083.
      View in: PubMed
    15. Faulkner P, Ghahremani DG, Tyndale RF, Hellemann G, London ED. Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers. Int J Neuropsychopharmacol. 2018 09 01; 21(9):800-808. PMID: 29924326.
      View in: PubMed
    16. Zheutlin AB, Chekroud AM, Polimanti R, Gelernter J, Sabb FW, Bilder RM, Freimer N, London ED, Hultman CM, Cannon TD. Multivariate Pattern Analysis of Genotype-Phenotype Relationships in Schizophrenia. Schizophr Bull. 2018 08 20; 44(5):1045-1052. PMID: 29534239.
      View in: PubMed
    17. Petersen N, London ED. Addiction and Dopamine: Sex Differences and Insights from Studies of Smoking. Curr Opin Behav Sci. 2018 Oct; 23:150-159. PMID: 30746429.
      View in: PubMed
    18. Lam M, Trampush JW, Yu J, Knowles E, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Glahn DC, Malhotra AK, Lencz T. Multi-Trait Analysis of GWAS and Biological Insights Into Cognition: A Response to Hill (2018). Twin Res Hum Genet. 2018 10; 21(5):394-397. PMID: 30001766.
      View in: PubMed
    19. Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, Nagel M, Awasthi S, Barr PB, Coleman JRI, Grasby KL, Hammerschlag AR, Kaminski JA, Karlsson R, Krapohl E, Lam M, Nygaard M, Reynolds CA, Trampush JW, Young H, Zabaneh D, Hägg S, Hansell NK, Karlsson IK, Linnarsson S, Montgomery GW, Muñoz-Manchado AB, Quinlan EB, Schumann G, Skene NG, Webb BT, White T, Arking DE, Avramopoulos D, Bilder RM, Bitsios P, Burdick KE, Cannon TD, Chiba-Falek O, Christoforou A, Cirulli ET, Congdon E, Corvin A, Davies G, Deary IJ, DeRosse P, Dickinson D, Djurovic S, Donohoe G, Conley ED, Eriksson JG, Espeseth T, Freimer NA, Giakoumaki S, Giegling I, Gill M, Glahn DC, Hariri AR, Hatzimanolis A, Keller MC, Knowles E, Koltai D, Konte B, Lahti J, Le Hellard S, Lencz T, Liewald DC, London E, Lundervold AJ, Malhotra AK, Melle I, Morris D, Need AC, Ollier W, Palotie A, Payton A, Pendleton N, Poldrack RA, Räikkönen K, Reinvang I, Roussos P, Rujescu D, Sabb FW, Scult MA, Smeland OB, Smyrnis N, Starr JM, Steen VM, Stefanis NC, Straub RE, Sundet K, Tiemeier H, Voineskos AN, Weinberger DR, Widen E, Yu J, Abecasis G, Andreassen OA, Breen G, Christiansen L, Debrabant B, Dick DM, Heinz A, Hjerling-Leffler J, Ikram MA, Kendler KS, Martin NG, Medland SE, Pedersen NL, Plomin R, Polderman TJC, Ripke S, van der Sluis S, Sullivan PF, Vrieze SI, Wright MJ, Posthuma D. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018 Jul; 50(7):912-919. PMID: 29942086.
      View in: PubMed
    20. Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, Hagenaars SP, Ritchie SJ, Marioni RE, Fawns-Ritchie C, Liewald DCM, Okely JA, Ahola-Olli AV, Barnes CLK, Bertram L, Bis JC, Burdick KE, Christoforou A, DeRosse P, Djurovic S, Espeseth T, Giakoumaki S, Giddaluru S, Gustavson DE, Hayward C, Hofer E, Ikram MA, Karlsson R, Knowles E, Lahti J, Leber M, Li S, Mather KA, Melle I, Morris D, Oldmeadow C, Palviainen T, Payton A, Pazoki R, Petrovic K, Reynolds CA, Sargurupremraj M, Scholz M, Smith JA, Smith AV, Terzikhan N, Thalamuthu A, Trompet S, van der Lee SJ, Ware EB, Windham BG, Wright MJ, Yang J, Yu J, Ames D, Amin N, Amouyel P, Andreassen OA, Armstrong NJ, Assareh AA, Attia JR, Attix D, Avramopoulos D, Bennett DA, Böhmer AC, Boyle PA, Brodaty H, Campbell H, Cannon TD, Cirulli ET, Congdon E, Conley ED, Corley J, Cox SR, Dale AM, Dehghan A, Dick D, Dickinson D, Eriksson JG, Evangelou E, Faul JD, Ford I, Freimer NA, Gao H, Giegling I, Gillespie NA, Gordon SD, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Hartmann AM, Hatzimanolis A, Heiss G, Holliday EG, Joshi PK, Kähönen M, Kardia SLR, Karlsson I, Kleineidam L, Knopman DS, Kochan NA, Konte B, Kwok JB, Le Hellard S, Lee T, Lehtimäki T, Li SC, Liu T, Koini M, London E, Longstreth WT, Lopez OL, Loukola A, Luck T, Lundervold AJ, Lundquist A, Lyytikäinen LP, Martin NG, Montgomery GW, Murray AD, Need AC, Noordam R, Nyberg L, Ollier W, Papenberg G, Pattie A, Polasek O, Poldrack RA, Psaty BM, Reppermund S, Riedel-Heller SG, Rose RJ, Rotter JI, Roussos P, Rovio SP, Saba Y, Sabb FW, Sachdev PS, Satizabal CL, Schmid M, Scott RJ, Scult MA, Simino J, Slagboom PE, Smyrnis N, Soumaré A, Stefanis NC, Stott DJ, Straub RE, Sundet K, Taylor AM, Taylor KD, Tzoulaki I, Tzourio C, Uitterlinden A, Vitart V, Voineskos AN, Kaprio J, Wagner M, Wagner H, Weinhold L, Wen KH, Widen E, Yang Q, Zhao W, Adams HHH, Arking DE, Bilder RM, Bitsios P, Boerwinkle E, Chiba-Falek O, Corvin A, De Jager PL, Debette S, Donohoe G, Elliott P, Fitzpatrick AL, Gill M, Glahn DC, Hägg S, Hansell NK, Hariri AR, Ikram MK, Jukema JW, Vuoksimaa E, Keller MC, Kremen WS, Launer L, Lindenberger U, Palotie A, Pedersen NL, Pendleton N, Porteous DJ, Räikkönen K, Raitakari OT, Ramirez A, Reinvang I, Rudan I, Schmidt R, Schmidt H, Schofield PW, Schofield PR, Starr JM, Steen VM, Trollor JN, Turner ST, Van Duijn CM, Villringer A, Weinberger DR, Weir DR, Wilson JF, Malhotra A, McIntosh AM, Gale CR, Seshadri S, Mosley TH, Bressler J, Lencz T, Deary IJ. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018 05 29; 9(1):2098. PMID: 29844566.
      View in: PubMed
    21. Dean AC, Morales AM, Hellemann G, London ED. Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness. Neuropsychopharmacology. 2018 07; 43(8):1745-1752. PMID: 29704001.
      View in: PubMed
    22. Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology. 2018 03; 43(4):925. PMID: 29422498.
      View in: PubMed
    23. Ghahremani DG, Faulkner P, M Cox C, London ED. Behavioral and neural markers of cigarette-craving regulation in young-adult smokers during abstinence and after smoking. Neuropsychopharmacology. 2018 06; 43(7):1616-1622. PMID: 29472643.
      View in: PubMed
    24. Lam M, Trampush JW, Yu J, Knowles E, Davies G, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets. Cell Rep. 2017 Nov 28; 21(9):2597-2613. PMID: 29186694.
      View in: PubMed
    25. Petersen N, Ghahremani DG, Rapkin AJ, Berman SM, Liang L, London ED. Brain activation during emotion regulation in women with premenstrual dysphoric disorder. Psychol Med. 2018 08; 48(11):1795-1802. PMID: 29145910.
      View in: PubMed
    26. Faulkner P, Petersen N, Ghahremani DG, Cox CM, Tyndale RF, Hellemann GS, London ED. Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers. Psychopharmacology (Berl). 2018 01; 235(1):193-202. PMID: 29022071.
      View in: PubMed
    27. Weinstein AM, Rosca P, Fattore L, London ED. Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Front Psychiatry. 2017; 8:156. PMID: 28878698.
      View in: PubMed
    28. Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users. Neuropsychopharmacology. 2018 03; 43(4):751-760. PMID: 28664927.
      View in: PubMed
    29. Guttman Z, Moeller SJ, London ED. Neural underpinnings of maladaptive decision-making in addictions. Pharmacol Biochem Behav. 2018 01; 164:84-98. PMID: 28666893.
      View in: PubMed
    30. Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology (Berl). 2017 Jul; 234(13):1997-2007. PMID: 28357460.
      View in: PubMed
    31. Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology. 2017 Jul; 42(8):1630-1639. PMID: 28262740.
      View in: PubMed
    32. Verdejo-Garcia A, Chong TT, Stout JC, Yücel M, London ED. Stages of dysfunctional decision-making in addiction. Pharmacol Biochem Behav. 2018 01; 164:99-105. PMID: 28216068.
      View in: PubMed
    33. Kohno M, Morales AM, Guttman Z, London ED. A neural network that links brain function, white-matter structure and risky behavior. Neuroimage. 2017 04 01; 149:15-22. PMID: 28131889.
      View in: PubMed
    34. Faulkner P, Ghahremani DG, Tyndale RF, Cox CM, Kazanjian AS, Paterson N, Lotfipour S, Hellemann GS, Petersen N, Vigil C, London ED. Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. Neuropsychopharmacology. 2017 Jul; 42(8):1610-1618. PMID: 28117337.
      View in: PubMed
    35. Okita K, Mandelkern MA, London ED. Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence. Int J Neuropsychopharmacol. 2016 11; 19(11). PMID: 27634830.
      View in: PubMed
    36. Weinstein AM, Freedman N, Greif J, Yemini Z, Mishani E, London E, Chisin R, Bocher M. Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment. Am J Addict. 2016 09; 25(6):486-92. PMID: 27467186.
      View in: PubMed
    37. Hofmeyr A, Monterosso J, Dean AC, Morales AM, Bilder RM, Sabb FW, London ED. Mixture models of delay discounting and smoking behavior. Am J Drug Alcohol Abuse. 2017 05; 43(3):271-280. PMID: 27439543.
      View in: PubMed
    38. Jones HW, Dean AC, Price KA, London ED. Increased self-reported impulsivity in methamphetamine users maintaining drug abstinence. Am J Drug Alcohol Abuse. 2016 09; 42(5):500-506. PMID: 27398730.
      View in: PubMed
    39. Okita K, Petersen N, Robertson CL, Dean AC, Mandelkern MA, London ED. Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence. Neuropsychopharmacology. 2016 11; 41(12):2913-2919. PMID: 27329684.
      View in: PubMed
    40. Petersen N, London ED, Liang L, Ghahremani DG, Gerards R, Goldman L, Rapkin AJ. Emotion regulation in women with premenstrual dysphoric disorder. Arch Womens Ment Health. 2016 10; 19(5):891-8. PMID: 27155663.
      View in: PubMed
    41. Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals. Int J Neuropsychopharmacol. 2016 05; 19(5). PMID: 26657175; PMCID: PMC4886668.
    42. London ED. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling. Adv Pharmacol. 2016; 76:67-84. PMID: 27288074.
      View in: PubMed
    43. Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend. 2016 Apr 01; 161:163-70. PMID: 26880595; PMCID: PMC4792713 [Available on 04/01/17].
    44. Thorberg FA, Young RM, Sullivan KA, Lyvers M, Hurst CP, Connor JP, Tyssen R, London ED, Noble EP, Feeney GF. A longitudinal mediational study on the stability of alexithymia among alcohol-dependent outpatients in cognitive-behavioral therapy. Psychol Addict Behav. 2016 Feb; 30(1):64-72. PMID: 26795394.
      View in: PubMed
    45. Thorberg FA, Young RM, Lyvers M, Sullivan KA, Hasking P, London ED, Tyssen R, Connor JP, Feeney GFX. Alexithymia in relation to alcohol expectancies in alcohol-dependent outpatients. Psychiatry Res. 2016 Feb 28; 236:186-188. PMID: 26775551.
      View in: PubMed
    46. Ballard ME, Dean AC, Mandelkern MA, London ED. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users. PLoS One. 2015; 10(12):e0143510. PMID: 26657223.
      View in: PubMed
    47. Moeller SJ, London ED, Northoff G. Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity. Neurosci Biobehav Rev. 2016 Feb; 61:35-52. PMID: 26657968; PMCID: PMC4731270 [Available on 02/01/17].
    48. Jarcho JM, Feier NA, Labus JS, Naliboff B, Smith SR, Hong JY, Colloca L, Tillisch K, Mandelkern MA, Mayer EA, London ED. Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response. Neuroimage Clin. 2016; 10:107-14. PMID: 26759785; PMCID: PMC4683423.
    49. Mackey S, Kan KJ, Chaarani B, Alia-Klein N, Batalla A, Brooks S, Cousijn J, Dagher A, de Ruiter M, Desrivieres S, Feldstein Ewing SW, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hutchison K, Li CS, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Morales AM, Paulus MP, Paus T, Pearlson G, Schluter R, Momenan R, Schmaal L, Schumann G, Sinha R, Sjoerds Z, Stein DJ, Stein EA, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Walter H, Wright MJ, Yucel M, Yurgelun-Todd D, Hibar DP, Jahanshad N, Thompson PM, Glahn DC, Garavan H, Conrod P. Genetic imaging consortium for addiction medicine: From neuroimaging to genes. Prog Brain Res. 2016; 224:203-23. PMID: 26822360; PMCID: PMC4820288 [Available on 01/01/17].
    50. London ED. Consequences of Adolescent Smoking: Cognitive Performance, Brain Function, and Policy Implications. Biol Psychiatry. 2015 Nov 01; 78(9):596-7. PMID: 26434629.
      View in: PubMed
    51. Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment. Neuropsychopharmacology. 2016 May; 41(6):1629-36. PMID: 26503310; PMCID: PMC4832026 [Available on 05/01/17].
    52. Haut KM, Karlsgodt KH, Bilder RM, Congdon E, Freimer NB, London ED, Sabb FW, Ventura J, Cannon TD. Memory systems in schizophrenia: Modularity is preserved but deficits are generalized. Schizophr Res. 2015 Oct; 168(1-2):223-30. PMID: 26299707; PMCID: PMC4591239 [Available on 10/01/16].
    53. Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, London ED. Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. Neuropsychopharmacology. 2016 Feb; 41(3):695-703. PMID: 26119471; PMCID: PMC4707816 [Available on 02/01/17].
    54. Robertson CL, Ishibashi K, Mandelkern MA, Brown AK, Ghahremani DG, Sabb F, Bilder R, Cannon T, Borg J, London ED. Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects. J Neurosci. 2015 Apr 15; 35(15):5990-7. PMID: 25878272; PMCID: PMC4397600.
    55. Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology. 2015 Sep; 40(10):2347-56. PMID: 25801501; PMCID: PMC4538349.
    56. Dean AC, Kohno M, Morales AM, Ghahremani DG, London ED. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain. Drug Alcohol Depend. 2015 Jun 01; 151:84-91. PMID: 25840750; PMCID: PMC4447566.
    57. Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence. Int J Neuropsychopharmacol. 2015 Jan 20; 18(7):pyu119. PMID: 25603861.
      View in: PubMed
    58. London ED, Kohno M, Morales AM, Ballard ME. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res. 2015 Dec 02; 1628(Pt A):174-85. PMID: 25451127.
      View in: PubMed
    59. O'Neill J, Tobias MC, Hudkins M, London ED. Glutamatergic neurometabolites during early abstinence from chronic methamphetamine abuse. Int J Neuropsychopharmacol. 2014 Oct 31; 18(3). PMID: 25522400; PMCID: PMC4360253.
    60. Groman SM, James AS, Seu E, Tran S, Clark TA, Harpster SN, Crawford M, Burtner JL, Feiler K, Roth RH, Elsworth JD, London ED, Jentsch JD. In the blink of an eye: relating positive-feedback sensitivity to striatal dopamine D2-like receptors through blink rate. J Neurosci. 2014 Oct 22; 34(43):14443-54. PMID: 25339755.
      View in: PubMed
    61. Dean AC, Kohno M, Hellemann G, London ED. Childhood maltreatment and amygdala connectivity in methamphetamine dependence: a pilot study. Brain Behav. 2014; 4(6):867-76. PMID: 25365801; PMCID: PMC4178299.
    62. Rapkin AJ, Berman SM, London ED. The Cerebellum and Premenstrual Dysphoric Disorder. AIMS Neurosci. 2014; 1(2):120-141. PMID: 28275721.
      View in: PubMed
    63. Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED. Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry. 2014 Jul 01; 71(7):812-20. PMID: 24850532; PMCID: PMC4119006.
    64. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):35-44. PMID: 24949564; PMCID: PMC4365972.
    65. Courtney KE, Ghahremani DG, London ED, Ray LA. The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug Alcohol Depend. 2014 Aug 01; 141:21-6. PMID: 24880692; PMCID: PMC4166553.
    66. London ED, Ghahremani DG. Large-scale brain network coupling as a potential neural metric for nicotine abstinence effects on craving and cognitive function. JAMA Psychiatry. 2014 May; 71(5):491-2. PMID: 24622823.
      View in: PubMed
    67. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl). 2014 Oct; 231(19):3843-53. PMID: 24733235; PMCID: PMC4161630.
    68. Morales AM, Ghahremani D, Kohno M, Hellemann GS, London ED. Cigarette exposure, dependence, and craving are related to insula thickness in young adult smokers. Neuropsychopharmacology. 2014 Jul; 39(8):1816-22. PMID: 24584328; PMCID: PMC4059909.
    69. O'Neill J, Tobias MC, Hudkins M, Oh EY, Hellemann GS, Nurmi EL, London ED. Thalamic glutamate decreases with cigarette smoking. Psychopharmacology (Berl). 2014 Jul; 231(13):2717-24. PMID: 24535652; PMCID: PMC4182312.
    70. Congdon E, Altshuler LL, Mumford JA, Karlsgodt KH, Sabb FW, Ventura J, McGough JJ, London ED, Cannon TD, Bilder RM, Poldrack RA. Neural activation during response inhibition in adult attention-deficit/hyperactivity disorder: preliminary findings on the effects of medication and symptom severity. Psychiatry Res. 2014 Apr 30; 222(1-2):17-28. PMID: 24581734; PMCID: PMC4009011.
    71. Helfinstein SM, Schonberg T, Congdon E, Karlsgodt KH, Mumford JA, Sabb FW, Cannon TD, London ED, Bilder RM, Poldrack RA. Predicting risky choices from brain activity patterns. Proc Natl Acad Sci U S A. 2014 Feb 18; 111(7):2470-5. PMID: 24550270; PMCID: PMC3932884.
    72. Ivanov I, Liu X, Clerkin S, Schulz K, Fan J, Friston K, London ED, Schwartz J, Newcorn JH. Methylphenidate and brain activity in a reward/conflict paradigm: role of the insula in task performance. Eur Neuropsychopharmacol. 2014 Jun; 24(6):897-906. PMID: 24491951.
      View in: PubMed
    73. White CN, Congdon E, Mumford JA, Karlsgodt KH, Sabb FW, Freimer NB, London ED, Cannon TD, Bilder RM, Poldrack RA. Decomposing decision components in the stop-signal task: a model-based approach to individual differences in inhibitory control. J Cogn Neurosci. 2014 Aug; 26(8):1601-14. PMID: 24405185; PMCID: PMC4119005.
    74. Paterson NE, Vocci F, Sevak RJ, Wagreich E, London ED. Dopamine D3 receptors as a therapeutic target for methamphetamine dependence. Am J Drug Alcohol Abuse. 2014 Jan; 40(1):1-9. PMID: 24359505.
      View in: PubMed
    75. Mooney LJ, Cooper C, London ED, Chudzynski J, Dolezal B, Dickerson D, Brecht ML, Peñate J, Rawson RA. Exercise for methamphetamine dependence: rationale, design, and methodology. Contemp Clin Trials. 2014 Jan; 37(1):139-47. PMID: 24291456; PMCID: PMC4431553.
    76. Ishibashi K, Robertson CL, Mandelkern MA, Morgan AT, London ED. The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region. Mol Imaging. 2013 Nov-Dec; 12(8). PMID: 24447617; PMCID: PMC4103900.
    77. Congdon E, Bato AA, Schonberg T, Mumford JA, Karlsgodt KH, Sabb FW, London ED, Cannon TD, Bilder RM, Poldrack RA. Differences in neural activation as a function of risk-taking task parameters. Front Neurosci. 2013; 7:173. PMID: 24137106; PMCID: PMC3786224.
    78. Kohno M, Ghahremani DG, Morales AM, Robertson CL, Ishibashi K, Morgan AT, Mandelkern MA, London ED. Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex. 2015 Jan; 25(1):236-45. PMID: 23966584.
      View in: PubMed
    79. Swanson AN, Shoptaw S, Heinzerling KG, Wade AC, Worley M, McCracken J, Wilson SA, Asarnow J, London ED. Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles. Subst Use Misuse. 2013 Dec; 48(14):1553-62. PMID: 23822739.
      View in: PubMed
    80. Groman SM, Morales AM, Lee B, London ED, Jentsch JD. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology (Berl). 2013 Oct; 229(3):527-38. PMID: 23748383; PMCID: PMC3770792.
    81. Thakkar KN, Congdon E, Poldrack RA, Sabb FW, London ED, Cannon TD, Bilder RM. Women are more sensitive than men to prior trial events on the Stop-signal task. Br J Psychol. 2014 May; 105(2):254-72. PMID: 24754812; PMCID: PMC4000536.
    82. Galván A, Schonberg T, Mumford J, Kohno M, Poldrack RA, London ED. Greater risk sensitivity of dorsolateral prefrontal cortex in young smokers than in nonsmokers. Psychopharmacology (Berl). 2013 Sep; 229(2):345-55. PMID: 23644912; PMCID: PMC3758460.
    83. Ghahremani DG, Oh EY, Dean AC, Mouzakis K, Wilson KD, London ED. Effects of the Youth Empowerment Seminar on impulsive behavior in adolescents. J Adolesc Health. 2013 Jul; 53(1):139-41. PMID: 23601502.
      View in: PubMed
    84. Reise SP, Moore TM, Sabb FW, Brown AK, London ED. The Barratt Impulsiveness Scale-11: reassessment of its structure in a community sample. Psychol Assess. 2013 Jun; 25(2):631-42. PMID: 23544402.
      View in: PubMed
    85. Jarcho JM, Feier NA, Bert A, Labus JA, Lee M, Stains J, Ebrat B, Groman SM, Tillisch K, Brody AL, London ED, Mandelkern MA, Mayer EA. Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain. Pain. 2013 Jul; 154(7):987-96. PMID: 23582152; PMCID: PMC4294187.
    86. Berman SM, Paz-Filho G, Wong ML, Kohno M, Licinio J, London ED. Effects of leptin deficiency and replacement on cerebellar response to food-related cues. Cerebellum. 2013 Feb; 12(1):59-67. PMID: 22576622.
      View in: PubMed
    87. Dean AC, Groman SM, Morales AM, London ED. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology. 2013 Jan; 38(2):259-74. PMID: 22948978.
      View in: PubMed
    88. Berman SM, London ED, Morgan M, Rapkin AJ. Elevated gray matter volume of the emotional cerebellum in women with premenstrual dysphoric disorder. J Affect Disord. 2013 Apr 05; 146(2):266-71. PMID: 22868063; PMCID: PMC3529750.
    89. Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N, Brown AK, Monterosso JR, Aron AR, Mandelkern MA, Poldrack RA, London ED. Striatal dopamine D2/D3 receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci. 2012 May 23; 32(21):7316-24. PMID: 22623677; PMCID: PMC3517177.
    90. Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA, London ED, Jentsch JD. Dysregulation of D2-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci. 2012 Apr 25; 32(17):5843-52. PMID: 22539846; PMCID: PMC3353813.
    91. Payer DE, Baicy K, Lieberman MD, London ED. Overlapping neural substrates between intentional and incidental down-regulation of negative emotions. Emotion. 2012 Apr; 12(2):229-35. PMID: 22468617; PMCID: PMC4111128.
    92. Morales AM, Lee B, Hellemann G, O'Neill J, London ED. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend. 2012 Oct 01; 125(3):230-8. PMID: 22445480.
      View in: PubMed
    93. Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain. 2012 Apr; 153(4):744-54. PMID: 22386471.
      View in: PubMed
    94. Ivanov I, Liu X, Shulz K, Fan J, London E, Friston K, Halperin JM, Newcorn JH. Parental substance abuse and function of the motivation and behavioral inhibition systems in drug-naïve youth. Psychiatry Res. 2012 Feb 28; 201(2):128-35. PMID: 22386967.
      View in: PubMed
    95. Canamar CP, London E. Acute cigarette smoking reduces latencies on a Smoking Stroop test. Addict Behav. 2012 May; 37(5):627-31. PMID: 22325952.
      View in: PubMed
    96. Brown AK, Mandelkern MA, Farahi J, Robertson C, Ghahremani DG, Sumerel B, Moallem N, London ED. Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers. Int J Neuropsychopharmacol. 2012 Aug; 15(7):989-94. PMID: 22243762; PMCID: PMC4113216.
    97. Hudkins M, O'Neill J, Tobias MC, Bartzokis G, London ED. Cigarette smoking and white matter microstructure. Psychopharmacology (Berl). 2012 May; 221(2):285-95. PMID: 22215225; PMCID: PMC4111107.
    98. Dean AC, Hellemann G, Sugar CA, London ED. Educational attainment is not a good proxy for cognitive function in methamphetamine dependence. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):249-54. PMID: 22206606; PMCID: PMC4111102.
    99. Nestor LJ, Ghahremani DG, Monterosso J, London ED. Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res. 2011 Dec 30; 194(3):287-295. PMID: 22047731.
      View in: PubMed
    100. Dean AC, Sevak RJ, Monterosso JR, Hellemann G, Sugar CA, London ED. Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs. 2011 Nov; 72(6):943-53. PMID: 22051208; PMCID: PMC3211965.
    101. London ED, Berman SM, Chakrapani S, Delibasi T, Monterosso J, Erol HK, Paz-Filho G, Wong ML, Licinio J. Short-term plasticity of gray matter associated with leptin deficiency and replacement. J Clin Endocrinol Metab. 2011 Aug; 96(8):E1212-20. PMID: 21613360; PMCID: PMC3146795.
    102. Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K, Rivera R, Dahlbom M, Sossi V, Vandervoort E, Jentsch JD. Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci. 2011 May 18; 31(20):7291-9. PMID: 21593313; PMCID: PMC3114883.
    103. Zorick T, Sugar CA, Hellemann G, Shoptaw S, London ED. Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):500-3. PMID: 21592681; PMCID: PMC3181284.
    104. Brody AL, Mandelkern MA, London ED, Khan A, Kozman D, Costello MR, Vellios EE, Archie MM, Bascom R, Mukhin AG. Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Arch Gen Psychiatry. 2011 Sep; 68(9):953-60. PMID: 21536968; PMCID: PMC3380615.
    105. Tabibnia G, Monterosso JR, Baicy K, Aron AR, Poldrack RA, Chakrapani S, Lee B, London ED. Different forms of self-control share a neurocognitive substrate. J Neurosci. 2011 Mar 30; 31(13):4805-10. PMID: 21451018; PMCID: PMC3096483.
    106. Dean AC, Sugar CA, Hellemann G, London ED. Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test. Psychopharmacology (Berl). 2011 Jun; 215(4):801-11. PMID: 21293849.
      View in: PubMed
    107. Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, Poldrack RA, London ED. Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology. 2011 Apr; 36(5):950-9. PMID: 21289606; PMCID: PMC3077264.
    108. Galván A, Poldrack RA, Baker CM, McGlennen KM, London ED. Neural correlates of response inhibition and cigarette smoking in late adolescence. Neuropsychopharmacology. 2011 Apr; 36(5):970-8. PMID: 21270772; PMCID: PMC3077266.
    109. Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody AL. Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. Arch Gen Psychiatry. 2011 May; 68(5):505-15. PMID: 21199957; PMCID: PMC3214639.
    110. Zorick T, Mandelkern MA, Lee B, Wong ML, Miotto K, Shabazian J, London ED. Elevated plasma prolactin in abstinent methamphetamine-dependent subjects. Am J Drug Alcohol Abuse. 2011 Jan; 37(1):62-7. PMID: 21142706; PMCID: PMC3056536.
    111. Rapkin AJ, Berman SM, Mandelkern MA, Silverman DH, Morgan M, London ED. Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry. 2011 Feb 15; 69(4):374-80. PMID: 21092938; PMCID: PMC3053132.
    112. Payer DE, Lieberman MD, London ED. Neural correlates of affect processing and aggression in methamphetamine dependence. Arch Gen Psychiatry. 2011 Mar; 68(3):271-82. PMID: 21041607.
      View in: PubMed
    113. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, Rawson R, London ED. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010 Oct; 105(10):1809-18. PMID: 20840201; PMCID: PMC3071736.
    114. Brody AL, London ED, Olmstead RE, Allen-Martinez Z, Shulenberger S, Costello MR, Abrams AL, Scheibal D, Farahi J, Shoptaw S, Mandelkern MA. Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence. Psychiatry Res. 2010 Sep 30; 183(3):218-24. PMID: 20682457; PMCID: PMC2947623.
    115. Culbertson C, Nicolas S, Zaharovits I, London ED, De La Garza R, Brody AL, Newton TF. Methamphetamine craving induced in an online virtual reality environment. Pharmacol Biochem Behav. 2010 Oct; 96(4):454-60. PMID: 20643158; PMCID: PMC2951480.
    116. Simon SL, Dean AC, Cordova X, Monterosso JR, London ED. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs. 2010 May; 71(3):335-44. PMID: 20409426; PMCID: PMC2859784.
    117. Bauer M, Berman SM, Schlagenhauf F, Voytek B, Rasgon N, Mandelkern MA, Whybrow PC, London ED. Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: effects of levothyroxine. Psychiatry Res. 2010 Jan 30; 181(1):71-6. PMID: 19962861.
      View in: PubMed
    118. Tobias MC, O'Neill J, Hudkins M, Bartzokis G, Dean AC, London ED. White-matter abnormalities in brain during early abstinence from methamphetamine abuse. Psychopharmacology (Berl). 2010 Mar; 209(1):13-24. PMID: 20101394; PMCID: PMC2819660.
    119. Zorick T, Sevak RJ, Miotto K, Shoptaw S, Swanson AN, Clement C, De La Garza R, Newton TF, London ED. Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J Exp Pharmacol. 2010; 2:13-8. PMID: 27186086; PMCID: PMC4863281.
    120. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci. 2009 Nov 25; 29(47):14734-40. PMID: 19940168; PMCID: PMC2822639.
    121. London ED, Berman SM, Mohammadian P, Ritchie T, Mandelkern MA, Susselman MK, Schlagenhauf F, Noble EP. Effect of the TaqIA polymorphism on ethanol response in the brain. Psychiatry Res. 2009 Dec 30; 174(3):163-70. PMID: 19914044.
      View in: PubMed
    122. Azizian A, Nestor LJ, Payer D, Monterosso JR, Brody AL, London ED. Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task. Neuropsychopharmacology. 2010 Feb; 35(3):775-82. PMID: 19907418; PMCID: PMC2813980.
    123. Costello MR, Mandelkern MA, Shoptaw S, Shulenberger S, Baker SK, Abrams AL, Xia C, London ED, Brody AL. Effects of treatment for tobacco dependence on resting cerebral glucose metabolism. Neuropsychopharmacology. 2010 Feb; 35(3):605-12. PMID: 19865076; PMCID: PMC2813904.
    124. Ernst M, Luckenbaugh DA, Moolchan ET, Temple VA, Jenness J, Korelitz KE, London ED, Kimes AS. Decision-making and facial emotion recognition as predictors of substance-use initiation among adolescents. Addict Behav. 2010 Mar; 35(3):286-9. PMID: 19914005.
      View in: PubMed
    125. De La Garza R, Zorick T, London ED, Newton TF. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):173-80. PMID: 19781865; PMCID: PMC2815156.
    126. Berman SM, Noble EP, Mohammadian P, Ritchie T, Mandelkern MA, London ED. Laterality of cortical response to ethanol is moderated by TaqIA A1 allele. Synapse. 2009 Sep; 63(9):817-21. PMID: 19504620.
      View in: PubMed
    127. De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2009 Nov; 94(1):186-93. PMID: 19698734; PMCID: PMC2775447.
    128. Rao U, Hammen CL, London ED, Poland RE. Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents. Neuropsychopharmacology. 2009 Dec; 34(13):2721-32. PMID: 19693006; PMCID: PMC2784160.
    129. Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA. Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry. 2009 Nov 01; 66(9):898-901. PMID: 19640507; PMCID: PMC2763050.
    130. Dean AC, London ED, Sugar CA, Kitchen CM, Swanson AN, Heinzerling KG, Kalechstein AD, Shoptaw S. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):48-55. PMID: 19608354; PMCID: PMC2754143.
    131. Prosser J, London ED, Galynker II. Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Drug Alcohol Depend. 2009 Oct 01; 104(3):228-40. PMID: 19608356.
      View in: PubMed
    132. London ED. Studying addiction in the age of neuroimaging. Marian W. Fischman Lecture given at the 2008 meeting of CPDD. Drug Alcohol Depend. 2009 Feb 01; 100(1-2):182-5. PMID: 19160567.
      View in: PubMed
    133. Azizian A, Monterosso J, O'Neill J, London ED. Magnetic resonance imaging studies of cigarette smoking. Handb Exp Pharmacol. 2009; (192):113-43. PMID: 19184648.
      View in: PubMed
    134. Henningfield JE, London ED, Pogun S. Handbook of experimental pharmacology 192. Nicotine psychopharmacology. Preface. Handb Exp Pharmacol. 2009; (192):v-viii. PMID: 19301485.
      View in: PubMed
    135. Prosser JM, Eisenberg D, Davey EE, Steinfeld M, Cohen LJ, London ED, Galynker II. Character pathology and neuropsychological test performance in remitted opiate dependence. Subst Abuse Treat Prev Policy. 2008 Nov 19; 3:23. PMID: 19019247; PMCID: PMC2633291.
    136. Xu J, Azizian A, Monterosso J, Domier CP, Brody AL, Fong TW, London ED. Gender effects on mood and cigarette craving during early abstinence and resumption of smoking. Nicotine Tob Res. 2008 Nov; 10(11):1653-61. PMID: 18988078; PMCID: PMC2774521.
    137. Berman S, O'Neill J, Fears S, Bartzokis G, London ED. Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci. 2008 Oct; 1141:195-220. PMID: 18991959.
      View in: PubMed
    138. Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J, London ED, Olmstead RE, Rose JE, Mukhin AG. Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol. 2009 Apr; 12(3):305-16. PMID: 18706128; PMCID: PMC2773668.
    139. Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology. 2009 Jan; 34(2):282-9. PMID: 18563061; PMCID: PMC2777990.
    140. Azizian A, Monterosso JR, Brody AL, Simon SL, London ED. Severity of nicotine dependence moderates performance on perceptual-motor tests of attention. Nicotine Tob Res. 2008 Apr; 10(4):599-606. PMID: 18418782; PMCID: PMC2773663.
    141. Ivanov I, Schulz KP, London ED, Newcorn JH. Inhibitory control deficits in childhood and risk for substance use disorders: a review. Am J Drug Alcohol Abuse. 2008; 34(3):239-58. PMID: 18428067.
      View in: PubMed
    142. Baicy K, London ED, Monterosso J, Wong ML, Delibasi T, Sharma A, Licinio J. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A. 2007 Nov 13; 104(46):18276-9. PMID: 17986612; PMCID: PMC2084333.
    143. Payer DE, Lieberman MD, Monterosso JR, Xu J, Fong TW, London ED. Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task. Drug Alcohol Depend. 2008 Jan 11; 93(1-2):93-102. PMID: 17964741; PMCID: PMC2270785.
    144. Maki PM, Ernst M, London ED, Mordecai KL, Perschler P, Durso SC, Brandt J, Dobs A, Resnick SM. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab. 2007 Nov; 92(11):4107-14. PMID: 17726086.
      View in: PubMed
    145. Domier CP, Monterosso JR, Brody AL, Simon SL, Mendrek A, Olmstead R, Jarvik ME, Cohen MS, London ED. Effects of cigarette smoking and abstinence on Stroop task performance. Psychopharmacology (Berl). 2007 Nov; 195(1):1-9. PMID: 17634928; PMCID: PMC2796691.
    146. Galynker II, Eisenberg D, Matochik JA, Gertmenian-King E, Cohen L, Kimes AS, Contoreggi C, Kurian V, Ernst M, Rosenthal RN, Prosser J, London ED. Cerebral metabolism and mood in remitted opiate dependence. Drug Alcohol Depend. 2007 Oct 08; 90(2-3):166-74. PMID: 17521829; PMCID: PMC2063442.
    147. Monterosso JR, Ainslie G, Xu J, Cordova X, Domier CP, London ED. Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp. 2007 May; 28(5):383-93. PMID: 16944492.
      View in: PubMed
    148. Chefer SI, Kimes AS, Matochik JA, Horti AG, Kurian V, Shumway D, Domino EF, London ED, Mukhin AG. Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys. Neuropsychopharmacology. 2008 Jan; 33(2):270-8. PMID: 17429408.
      View in: PubMed
    149. Baicy K, London ED. Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction. 2007 Apr; 102 Suppl 1:5-15. PMID: 17493049.
      View in: PubMed
    150. Lee B, Groman S, London ED, Jentsch JD. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology. 2007 Oct; 32(10):2125-34. PMID: 17299511.
      View in: PubMed
    151. Brody AL, Mandelkern MA, Olmstead RE, Jou J, Tiongson E, Allen V, Scheibal D, London ED, Monterosso JR, Tiffany ST, Korb A, Gan JJ, Cohen MS. Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry. 2007 Sep 15; 62(6):642-51. PMID: 17217932; PMCID: PMC1992815.
    152. Xu J, Mendrek A, Cohen MS, Monterosso J, Simon S, Jarvik M, Olmstead R, Brody AL, Ernst M, London ED. Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop Task. Neuropsychopharmacology. 2007 Jun; 32(6):1421-8. PMID: 17164821; PMCID: PMC2876092.
    153. Xu J, Mendrek A, Cohen MS, Monterosso J, Simon S, Brody AL, Jarvik M, Rodriguez P, Ernst M, London ED. Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: a preliminary study. Psychiatry Res. 2006 Dec 01; 148(2-3):103-9. PMID: 17088048; PMCID: PMC1817900.
    154. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, Brasic JR, Kimes AS, Maris MA, Kumar A, Contoreggi C, Links J, Ernst M, Rousset O, Zukin S, Grace AA, Lee JS, Rohde C, Jasinski DR, Gjedde A, London ED. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology. 2006 Dec; 31(12):2716-27. PMID: 16971900.
      View in: PubMed
    155. Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH. Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci. 2006 Aug 23; 26(34):8707-14. PMID: 16928859.
      View in: PubMed
    156. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006 Aug; 63(8):907-15. PMID: 16894067; PMCID: PMC2773659.
    157. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006 Jul; 63(7):808-16. PMID: 16818870; PMCID: PMC2873693.
    158. Ernst M, Luckenbaugh DA, Moolchan ET, Leff MK, Allen R, Eshel N, London ED, Kimes A. Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics. 2006 Jun; 117(6):2030-9. PMID: 16740845.
      View in: PubMed
    159. Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend. 2006 Oct 01; 84(3):240-7. PMID: 16545923; PMCID: PMC2067988.
    160. Obrzut SL, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. Nucl Med Biol. 2005 Nov; 32(8):869-74. PMID: 16253812.
      View in: PubMed
    161. Eisenberg DP, London ED, Matochik JA, Derbyshire S, Cohen LJ, Steinfeld M, Prosser J, Galynker II. Education-associated cortical glucose metabolism during sustained attention. Neuroreport. 2005 Sep 08; 16(13):1473-6. PMID: 16110274; PMCID: PMC2254316.
    162. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005 Nov 15; 58(10):770-8. PMID: 16095568.
      View in: PubMed
    163. Voytek B, Berman SM, Hassid BD, Simon SL, Mandelkern MA, Brody AL, Monterosso J, Ling W, London ED. Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers. Synapse. 2005 Aug; 57(2):113-5. PMID: 15906384.
      View in: PubMed
    164. Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, Brody A, Jarvik M, Domier CP, Olmstead R, Ernst M, London ED. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry. 2005 Jul 15; 58(2):143-50. PMID: 16038685; PMCID: PMC2773671.
    165. Mendrek A, Monterosso J, Simon SL, Jarvik M, Brody A, Olmstead R, Domier CP, Cohen MS, Ernst M, London ED. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav. 2006 May; 31(5):833-44. PMID: 16009504; PMCID: PMC2773651.
    166. Fishbein DH, Eldreth DL, Hyde C, Matochik JA, London ED, Contoreggi C, Kurian V, Kimes AS, Breeden A, Grant S. Risky decision making and the anterior cingulate cortex in abstinent drug abusers and nonusers. Brain Res Cogn Brain Res. 2005 Apr; 23(1):119-36. PMID: 15795139.
      View in: PubMed
    167. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 2005 Aug 01; 79(2):273-7. PMID: 15967595.
      View in: PubMed
    168. Matochik JA, London ED, Yildiz BO, Ozata M, Caglayan S, DePaoli AM, Wong ML, Licinio J. Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab. 2005 May; 90(5):2851-4. PMID: 15713712.
      View in: PubMed
    169. Fishbein D, Hyde C, Eldreth D, London ED, Matochik J, Ernst M, Isenberg N, Steckley S, Schech B, Kimes A. Cognitive performance and autonomic reactivity in abstinent drug abusers and nonusers. Exp Clin Psychopharmacol. 2005 Feb; 13(1):25-40. PMID: 15727501.
      View in: PubMed
    170. Gündisch D, Koren AO, Horti AG, Pavlova OA, Kimes AS, Mukhin AG, London ED. In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors. Synapse. 2005 Feb; 55(2):89-97. PMID: 15529332.
      View in: PubMed
    171. Baicy K, Bearden CE, Monterosso J, Brody AL, Isaacson AJ, London ED. Common substrates of dysphoria in stimulant drug abuse and primary depression: therapeutic targets. Int Rev Neurobiol. 2005; 65:117-45. PMID: 16140055.
      View in: PubMed
    172. Vaupel DB, Tella SR, Huso DL, Wagner VO, Mukhin AG, Chefer SI, Horti AG, London ED, Koren AO, Kimes AS. Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography. J Pharmacol Exp Ther. 2005 Jan; 312(1):355-65. PMID: 15331657.
      View in: PubMed
    173. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA. Smoking-induced ventral striatum dopamine release. Am J Psychiatry. 2004 Jul; 161(7):1211-8. PMID: 15229053.
      View in: PubMed
    174. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci. 2004 Jun 30; 24(26):6028-36. PMID: 15229250.
      View in: PubMed
    175. Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res. 2004 Apr 30; 130(3):269-81. PMID: 15135160; PMCID: PMC2773650.
    176. Matochik JA, Chefer SI, Lane MA, Roth GS, Mattison JA, London ED, Ingram DK. Age-related decline in striatal volume in rhesus monkeys: assessment of long-term calorie restriction. Neurobiol Aging. 2004 Feb; 25(2):193-200. PMID: 14749137.
      View in: PubMed
    177. Rotheram-Fuller E, Shoptaw S, Berman SM, London ED. Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug Alcohol Depend. 2004 Jan 07; 73(1):79-86. PMID: 14687962.
      View in: PubMed
    178. Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, Huang JC, Bota RG, Bartzokis G, London ED. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry. 2004 Jan 01; 55(1):77-84. PMID: 14706428.
      View in: PubMed
    179. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004 Jan; 61(1):73-84. PMID: 14706946.
      View in: PubMed
    180. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet J, Kimes A, Funderburk F, London E. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci. 2004; 16(4):456-64. PMID: 15616172; PMCID: PMC2771441.
    181. Fujita M, Ichise M, van Dyck CH, Zoghbi SS, Tamagnan G, Mukhin AG, Bozkurt A, Seneca N, Tipre D, DeNucci CC, Iida H, Vaupel DB, Horti AG, Koren AO, Kimes AS, London ED, Seibyl JP, Baldwin RM, Innis RB. Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET. Eur J Nucl Med Mol Imaging. 2003 Dec; 30(12):1620-9. PMID: 14523584.
      View in: PubMed
    182. Liu X, Koren AO, Yee SK, Pechnick RN, Poland RE, London ED. Self-administration of 5-iodo-A-85380, a beta2-selective nicotinic receptor ligand, by operantly trained rats. Neuroreport. 2003 Aug 06; 14(11):1503-5. PMID: 12960773.
      View in: PubMed
    183. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage. 2003 Jul; 19(3):1095-102. PMID: 12880835.
      View in: PubMed
    184. Ernst M, Kimes AS, London ED, Matochik JA, Eldreth D, Tata S, Contoreggi C, Leff M, Bolla K. Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2003 Jun; 160(6):1061-70. PMID: 12777263.
      View in: PubMed
    185. Kimes AS, Horti AG, London ED, Chefer SI, Contoreggi C, Ernst M, Friello P, Koren AO, Kurian V, Matochik JA, Pavlova O, Vaupel DB, Mukhin AG. 2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J. 2003 Jul; 17(10):1331-3. PMID: 12759330.
      View in: PubMed
    186. Chefer SI, London ED, Koren AO, Pavlova OA, Kurian V, Kimes AS, Horti AG, Mukhin AG. Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse. 2003 Apr; 48(1):25-34. PMID: 12557269.
      View in: PubMed
    187. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC, Turkington TG, Coleman RE. PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry. 2003 Feb; 160(2):323-33. PMID: 12562580.
      View in: PubMed
    188. Ernst M, Grant SJ, London ED, Contoreggi CS, Kimes AS, Spurgeon L. Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry. 2003 Jan; 160(1):33-40. PMID: 12505799.
      View in: PubMed
    189. Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR, Madsen D, Jarvik ME. Brain metabolic changes during cigarette craving. Arch Gen Psychiatry. 2002 Dec; 59(12):1162-72. PMID: 12470133.
      View in: PubMed
    190. Stapleton JM, Gilson SF, Wong DF, Villemagne VL, Dannals RF, Grayson RF, Henningfield JE, London ED. Intravenous nicotine reduces cerebral glucose metabolism: a preliminary study. Neuropsychopharmacology. 2003 Apr; 28(4):765-72. PMID: 12655323.
      View in: PubMed
    191. Obert JL, London ED, Rawson RA. Incorporating brain research findings into standard treatment: an example using the Matrix Model. J Subst Abuse Treat. 2002 Sep; 23(2):107-13. PMID: 12220608.
      View in: PubMed
    192. Ernst M, Bolla K, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, London ED. Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology. 2002 May; 26(5):682-91. PMID: 11927193.
      View in: PubMed
    193. Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL, Kurian V, Ernst M, London ED. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology. 2002 Mar; 26(3):376-86. PMID: 11850152.
      View in: PubMed
    194. Fujita M, Seibyl JP, Vaupel DB, Tamagnan G, Early M, Zoghbi SS, Baldwin RM, Horti AG, KoreN AO, Mukhin AG, Khan S, Bozkurt A, Kimes AS, London ED, Innis RB. Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects. Eur J Nucl Med Mol Imaging. 2002 Feb; 29(2):183-90. PMID: 11926380.
      View in: PubMed